Amicus Therapeutics, Inc. - Common Stock (NQ:FOLD)
9.030
+0.130
(+1.46%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 31, 2025
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 4,890,537 |
| Open | 8.900 |
| Bid (Size) | 8.770 (12) |
| Ask (Size) | 9.000 (1) |
| Prev. Close | 8.900 |
| Today's Range | 8.753 - 9.170 |
| 52wk Range | 5.510 - 12.65 |
| Shares Outstanding | 266,555,274 |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
This CSX Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
September 18, 2025
Earnings Scheduled For July 31, 2025
July 31, 2025
Earnings Scheduled For May 1, 2025
May 01, 2025
Amicus Therapeutics Earnings Preview
April 30, 2025
Amicus (FOLD) Q2 Revenue Jumps 22%
August 01, 2025
Frequently Asked Questions
Is Amicus Therapeutics, Inc. - Common Stock publicly traded?
Yes, Amicus Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Amicus Therapeutics, Inc. - Common Stock trade on?
Amicus Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Amicus Therapeutics, Inc. - Common Stock?
The ticker symbol for Amicus Therapeutics, Inc. - Common Stock is FOLD on the Nasdaq Stock Market
What is the current price of Amicus Therapeutics, Inc. - Common Stock?
The current price of Amicus Therapeutics, Inc. - Common Stock is 9.030
When was Amicus Therapeutics, Inc. - Common Stock last traded?
The last trade of Amicus Therapeutics, Inc. - Common Stock was at 10/31/25 04:00 PM ET
What is the market capitalization of Amicus Therapeutics, Inc. - Common Stock?
The market capitalization of Amicus Therapeutics, Inc. - Common Stock is 2.41B
How many shares of Amicus Therapeutics, Inc. - Common Stock are outstanding?
Amicus Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.